Related references
Note: Only part of the references are listed.Resolution of sickle cell disease-associated inflammation and tissue damage with 17R-resolvin D1
Alessandro Matte et al.
BLOOD (2019)
A Flow Cytometric Method for Isolating Cystic Fibrosis Airway Macrophages from Expectorated Sputum
Katherine B. Hisert et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2019)
Resolvin D1 regulates epithelial ion transport and inflammation in cystic fibrosis airways
Fiona C. Ringholz et al.
JOURNAL OF CYSTIC FIBROSIS (2018)
Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection
M. Codagnone et al.
MUCOSAL IMMUNOLOGY (2018)
Inflammation in cystic fibrosis: An update
Erica A. Roesch et al.
PEDIATRIC PULMONOLOGY (2018)
EMPIRE-CF: A phase II randomized placebo-controlled trial of once-daily, oral acebilustat in adult patients with cystic fibrosis - Study design and patient demographics
J. Stuart Elborn et al.
CONTEMPORARY CLINICAL TRIALS (2018)
In vitro Methods for the Development and Analysis of Human Primary Airway Epithelia
Ambra Gianotti et al.
FRONTIERS IN PHARMACOLOGY (2018)
Relevance of multidrug-resistant Pseudomonas aeruginosa infections in cystic fibrosis
S. Stefani et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2017)
Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del
Jennifer L. Taylor-Cousar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Pro-resolving lipid mediator Resolvin D1 serves as a marker of lung disease in cystic fibrosis
Olaf Eickmeier et al.
PLOS ONE (2017)
Testis Transcriptome Modulation in Klinefelter Patients with Hypospermatogenesis
Marco D'Aurora et al.
SCIENTIFIC REPORTS (2017)
Ezrin links CFTR to TLR4 signaling to orchestrate anti-bacterial immune response in macrophages
Caterina Di Pietro et al.
SCIENTIFIC REPORTS (2017)
microRNA-181b is increased in cystic fibrosis cells and impairs lipoxin A4 receptor-dependent mechanisms of inflammation resolution and antimicrobial defense
Anna Maria Pierdomenico et al.
SCIENTIFIC REPORTS (2017)
Restoring Cystic Fibrosis Transmembrane Conductance Regulator Function Reduces Airway Bacteria and Inflammation in People with Cystic Fibrosis and Chronic Lung Infections
Katherine B. Hisert et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
Interleukin-17 Pathophysiology and Therapeutic Intervention in Cystic Fibrosis Lung Infection and Inflammation
Daniel Hsu et al.
INFECTION AND IMMUNITY (2016)
Tracking the immunopathological response to Pseudomonas aeruginosa during respiratory infections
Cristina Cigana et al.
SCIENTIFIC REPORTS (2016)
Proresolving and cartilage-protective actions of resolvin D1 in inflammatory arthritis
Lucy V. Norling et al.
JCI INSIGHT (2016)
Use of ibuprofen to assess inflammatory biomarkers in induced sputum: Implications for clinical trials in cystic fibrosis
James F. Chmiel et al.
JOURNAL OF CYSTIC FIBROSIS (2015)
Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR
C. E. Wainwright et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Pseudomonas aeruginosa in Cystic Fibrosis Patients With G551D-CFTR Treated With Ivacaftor
Sonya L. Heltshe et al.
CLINICAL INFECTIOUS DISEASES (2015)
Considerations for the Conduct of Clinical Trials with Antiinflammatory Agents in Cystic Fibrosis A Cystic Fibrosis Foundation Workshop Report
Theodore J. Torphy et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2015)
Clinical Mechanism of the Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Ivacaftor in G551D-mediated Cystic Fibrosis
Steven M. Rowe et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Reduced 15-lipoxygenase 2 and lipoxin A4/leukotriene B4 ratio in children with cystic fibrosis
Fiona C. Ringholz et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
Immunoresolving actions of oral resolvin D1 include selective regulation of the transcription machinery in resolution-phase mouse macrophages
Antonio Recchiuti et al.
FASEB JOURNAL (2014)
LC-MS/MS method for rapid and concomitant quantification of pro-inflammatory and pro-resolving polyunsaturated fatty acid metabolites
Pauline Le Faouder et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2013)
Aspirin-triggered resolvin D1 reduces mucosal inflammation and promotes resolution in a murine model of acute lung injury
O. Eickmeier et al.
MUCOSAL IMMUNOLOGY (2013)
Resolvin D1 Limits Polymorphonuclear Leukocyte Recruitment to Inflammatory Loci Receptor-Dependent Actions
Lucy V. Norling et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Transcriptional regulation of the human FPR2/ALX gene: evidence of a heritable genetic variant that impairs promoter activity
Felice Simiele et al.
FASEB JOURNAL (2012)
Resolvin D1 and Aspirin-Triggered Resolvin D1 Promote Resolution of Allergic Airways Responses
Alexandre P. Rogerio et al.
JOURNAL OF IMMUNOLOGY (2012)
Infection regulates pro-resolving mediators that lower antibiotic requirements
Nan Chiang et al.
NATURE (2012)
MicroRNAs in resolution of acute inflammation: identification of novel resolvin D1-miRNA circuits
Antonio Recchiuti et al.
FASEB JOURNAL (2011)
Abnormal Trafficking and Degradation of TLR4 Underlie the Elevated Inflammatory Response in Cystic Fibrosis
Emanuela M. Bruscia et al.
JOURNAL OF IMMUNOLOGY (2011)
Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: impact on mediators and mechanisms of the inflammatory response
Domenico Mattoscio et al.
FASEB JOURNAL (2010)
Resolvin E1 Receptor Activation Signals Phosphorylation and Phagocytosis
Taisuke Ohira et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Resolvin D1 binds human phagocytes with evidence for proresolving receptors
Sriram Krishnamoorthy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis
Matthew Spite et al.
NATURE (2009)
Sequence diversity of the mucABD locus in Pseudomonas aeruginosa isolates from patients with cystic fibrosis
Alessandra Bragonzi et al.
MICROBIOLOGY-SGM (2006)
Down-regulation of the anti-inflammatory protein annexin A1 in cystic fibrosis knock-out mice and patients
N Bensalem et al.
MOLECULAR & CELLULAR PROTEOMICS (2005)
Cytokine levels in sputum of cystic fibrosis patients before and after antibiotic therapy
C Colombo et al.
PEDIATRIC PULMONOLOGY (2005)
Mechanisms of disease: Cystic fibrosis
SM Rowe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Molecular circuits of resolution: Formation and actions of resolvins and protectins
GL Bannenberg et al.
JOURNAL OF IMMUNOLOGY (2005)
Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway
CL Karp et al.
NATURE IMMUNOLOGY (2004)
Resolvins: A family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals
CN Serhan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Inflammation and infection in naive human cystic fibrosis airway grafts
R Tirouvanziam et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2000)